The 20 references in paper E. Efremova V., A. Shutov M., Е. Ефремова В., А. Шутов М. (2015) “Клинические особенности, качество жизни и прогноз больных с хроническим кардиоренальным синдромом // Clinical characteristics, quality of life and prognosis of patients with chronic cardiorenal syndrome” / spz:neicon:nefr:y:2015:i:2:p:63-67

1
RoncoC, HaapioC, HouseAA et al. Саrdiorenalsyndrome. J Am Coll Cardiol 2008;52(19):1527-1539
(check this in PDF content)
2
Шутов АМ, Серов ВА. Кардиоренальный и ренокардиальный синдромы. Нефрология 2009;13(4):59-63 [ShutovAM, Serov V A. Kardiorenal’nyj I renokardial’nyj sindromy. Nefrologija 2009;13 (4):59-63]
(check this in PDF content)
3
Серов ВА, Шутов АМ, Мензоров МВ и др. Эпидемиология хронической болезни почек у больных с хронической сердечной недостаточностью. Нефрология 2010; 14(1):5055 [SerovVA, ShutovAM, Menzorov MV i dr. Epidemiologija hronicheskoj bolezni pochek u bol’nyh s hronicheskoj serdechnoj nedostatochnost’ju. Nefrologija 2010; 14(1):50-55]
(check this in PDF content)
4
Aronow WS, Ahn C, Mercando AD, et al. Prevalence of CAD, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Card 2000;86:1142-1143.
(check this in PDF content)
5
Klein L, Massie BM, Leimberger JD et al. Admission or changes in renal function during hospitalization for worsening heart failure predict post-discharge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circ Heart Fail. 2008; 1 (l):25-33.
(check this in PDF content)
6
Weel C, Schellevis FG. Comorbidity and guidelines: conflicting interests. Lancet 2006; 367: 550–551
(check this in PDF content)
7
Агеев ФТ, Даниелян МО, Мареев ВЮ и др. Больные с хронической сердечной недостаточностью в Российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА–О–ХСН). Сердечная недостаточность 2008; 5(1):4–7. [Ageev FT, Danieljan MO, Mareev V Ju I dr. Bol’nye s hronicheskoj serdechnoj nedostatochnost’ju v rossijskoj ambulatornoj praktike: osobennosti kontingenta, diagnostiki I lechenija (po materialam issledovanija JePOHA–O–HSN). Serdechnaja nedostatochnost’ 2008; 5(1):4–7]
(check this in PDF content)
8
CharlsonME, PompeiP, AlesKL, MacKenzieCRAnewmethodofclassifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373–383
(check this in PDF content)
9
Смирнов АВ, Шилов ЕМ, Добронравов ВА, и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Нефрология 2012; 16 (1):89-115 [SmirnovAV, ShilovEM, DobronravovEA, idr. Nacional’nye rekomendacii. Hronicheskaja bolezn’ pochek: osnovnye principy skrininga, diagnostiki, profilaktiki i podhody k lecheniju. Nefrologija 2012; 16 (1):89-115]
(check this in PDF content)
10
Fortin M, Stewart M, Poitras ME et al. A systematic review of prevalence studies on multimorbidity: Toward a more uniform methodology. Ann Fam Med 2012;10(2):142–151.
(check this in PDF content)
11
Вёрткин А. Л., Скотников А. С. Коморбидность. Лечащий Врач 2013; 6: 66-68.[ Vjortkin A. L., Skotnikov A. S. Komorbidnost’. Lechashhij Vrach 2013; 6: 66-68]
(check this in PDF content)
12
Vincent M. van Deursen, Renato Urso, Cecile Laroche, et al. Co-morbidities in patients with heart failure:an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 2014;16: 103–111
(check this in PDF content)
13
Tsang TS, Barnes ME, Gersh BJ, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol 2003;42:1199-1205
(check this in PDF content)
14
Макеева ЕР, Шутов АМ, Серов ВА. Хроническая болезнь почек влияет на прогноз и стоимость стационарного лечения больных с хронической сердечной недостаточностью. Нефрология 2010;14 (2):51-55. [Makeeva ER, Shutov AM, Serov VA. Hronicheskaja bolezn' pochek vlijaet na prognoz i stoimost' stacionarnogo lechenija bol'nyh s hronicheskoj serdechnoj nedostatochnost'ju. Nefrologija 2010;14 (2):51-55]
(check this in PDF content)
15
Hillege HL, Nitsch D., Pfeffer M.A. et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation2006;113 (5):671-678
(check this in PDF content)
16
Lantelme P, Laurent S, Besnard C. Arterial stiffness is associated with left atrial size in hypertensive patients. Arch Cardiovasc Dis 2008;101:35-40
(check this in PDF content)
17
Kizer JR, Bella JN, Palmieri V et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006; 151:412–418
(check this in PDF content)
18
Watanabe H, Watanabe T, Sasaki S et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158(4):629-636
(check this in PDF content)
19
Шутов АМ, Серов ВА, Гердт АМ и др. Хроническая болезнь почек предрасполагает к фибрилляции предсердий у больных с хронической сердечной недостаточностью. Нефрология 2008; 12(4):49-53. [ShutovAM, SerovVA, GerdtAMidr. Hronicheskajabolezn’ pochek predraspolagaet k fibrilljacii predserdij u bol’nyh s hronicheskoj serdechnoj nedostatochnost’ju. Nefrologija 2008; 12(4):49-53]
(check this in PDF content)
20
Leon CF,.Grady KL, Eaton C et al. Quality of life in a diverse population of patients with heart failure. J Cardiopulm Rehabil Prev 2009; 29(3):171–178 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)